ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q4 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $237,000 | +33.1% | 1,372 | -2.5% | 0.01% | +25.0% |
| Q2 2021 | $178,000 | -7.3% | 1,407 | -0.4% | 0.00% | 0.0% |
| Q1 2021 | $192,000 | +23.1% | 1,413 | +15.6% | 0.00% | -33.3% |
| Q4 2020 | $156,000 | +32.2% | 1,222 | +15.0% | 0.01% | -14.3% |
| Q3 2020 | $118,000 | – | 1,063 | – | 0.01% | – |
| Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 6 | -71.4% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 21 | +40.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 15 | -53.1% | 0.00% | – |
| Q4 2015 | $2,000 | – | 32 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |